bioAffinity Technologies Earnings
NASDAQ: BIAFHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
1.65-0.20 (-10.81%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
bioAffinity Technologies earnings summary
In its most recent report on Nov 13, 2026 (Sep/2026), BIAF posted EPS of $-5.89. Revenue for the quarter was $1.1 million. Quarterly EPS is down 108.2% from the same quarter a year earlier.
Summary generated from market data by MetaCap's automated system. Methodology
BIAF earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 13, 2026 | — | $-5.89 | — | -25.0% |
| Nov 6, 2026 | — | $-3.94 | — | -19.0% |
| Aug 7, 2026 | — | $-0.64 | — | — |
| May 8, 2026 | — | $-0.81 | — | — |
| Mar 13, 2026 | — | $72.26 | — | — |
| Nov 14, 2025 | — | $-71.05 | — | — |
| Aug 14, 2025 | — | $-5.07 | — | — |
| May 15, 2025 | — | $-4.80 | — | — |
| Mar 31, 2025 | — | $-17.27 | — | — |
| Nov 14, 2024 | — | $-4.84 | — | — |
| Aug 14, 2024 | — | $-0.19 | — | — |
| May 15, 2024 | — | $-0.20 | — | — |
| Apr 1, 2024 | — | $-0.20 | — | — |
| Nov 14, 2023 | — | $-0.26 | — | — |
| Aug 14, 2023 | — | $-0.20 | — | — |
| May 15, 2023 | — | $-0.18 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.